Pterovita® and Pteroyouth®: Spanish biotechnology for cell resilience and chronic disease prevention
CIRCE Health Science has developed Pterovita® and Pteroyouth®, ingredients that combine the application of crystal engineering to multiply the bioavailability of polyphenols with synergistic mechanisms that enhance cellular resilience, reduce oxidative stress, and exert anti-inflammatory effects.
CIRCE Health Science is a Spanish biotechnology company specialized in the development and optimization of innovative ingredients for health and cosmetics. The creation of Pterovita® and Pteroyouth® represents a milestone that places Spanish biotechnology as an international benchmark in the field of cellular resilience and preventive medicine. This innovation, recognized in international scientific journals, is positioned as a key advance in the prevention of chronic diseases associated with aging and in radioprotection.
Aging is directly related to pathologies such as type 2 diabetes, cardiovascular diseases, cancer, and neurodegenerative disorders. Pterovita® and Pteroyouth® provide a biotechnological response to this challenge: thanks to its innovative technology, Pterovita® significantly improves the bioavailability of pterostilbene and enhances its effects on the activation of cellular repair mechanisms (SIRT1), control of oxidative damage (Nrf2), and reduction of inflammation. Pteroyouth® broadens and strengthens these effects by adding mitochondrial protection, making it an excellent solution to enhance both cellular and systemic resilience.
The results of this innovation have been published in international scientific journals and validated in preclinical models demonstrating benefits in cellular resilience and protection against ionizing radiation, even at lethal doses. Currently, CIRCE collaborates with hospitals and universities in clinical trials to evaluate its potential in preventing chronic diseases associated with aging, in radioprotection, and as a supplement to optimize cellular and systemic resilience.
“With Pterovita® and Pteroyouth®, we put Spanish biotechnology at the service of cellular defense and repair as a form of preventive medicine, offering scientific solutions that can transform people’s quality of life and reduce the burden of chronic diseases,” says Fernando Barrera, CEO of CIRCE Health Science.
This development reinforces CIRCE’s commitment to the innovation ecosystem, consolidating the role of Spanish biotechnology in the search for sustainable and scientifically validated answers to the major health challenges of our society.